Ikarian Capital LLC 13D and 13G filings for Odonate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:36 pm Sale |
2021-12-31 | 13G | Odonate Therapeutics, Inc. ODTC |
Ikarian Capital LLC | 0 3.500% |
-0 (-32.51%) |
Filing |
| 2021-07-02 4:05 pm Purchase |
2021-06-11 | 13G | Odonate Therapeutics, Inc. ODTC |
Ikarian Capital LLC | 0 5.200% |
0 (New Position) |
Filing |